Home

Steven J Schoch

CIK 1867508 · Chief Financial Officer · last filed 2026-06-22

Steven J Schoch is a Chief Financial Officer who has filed 9 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for ZURA, was dated Jun 22, 2026. 3 SEC filings were submitted jointly with ARENA PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

9

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
2748 BUSH STREET
SAN FRANCISCO, CA 94115
Related Filers
ARENA PHARMACEUTICALS INC — 3 joint filings, latest 2022-03-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZURA Director — $6.23 — $0 3 2026-06-22
Zura Bio Ltd (ZURAW) Delisted Director — $1.08 — $0 1 2023-05-22
Chrome Holding Co. (ME) Delisted Chief Financial Officer 10,583 $0.61 $6.4K $0 3 2022-08-22
ARENA PHARMACEUTICALS INC (ARNA) Delisted Director 0 $99.99 $0 $0 2 2022-03-11

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 ZURA Grant (A) — $0 EDGAR
2025-05-22 ZURA Grant (A) — $0 EDGAR
2024-12-11 ZURA Grant (A) — $0 EDGAR
2023-05-22 Zura Bio Ltd (ZURAW) Delisted Grant (A) — $0 EDGAR
2022-08-22 Chrome Holding Co. (ME) Delisted Tax (F) −4,782 -$15.9K EDGAR
2022-06-02 Chrome Holding Co. (ME) Delisted Tax (F) −4,782 -$13.5K EDGAR
2022-03-11 ARENA PHARMACEUTICALS INC (ARNA) Delisted Mixed −4,600 $0 EDGAR
2022-02-11 Chrome Holding Co. (ME) Delisted Grant (A) +221,227 $0 EDGAR
2021-06-15 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) +4,600 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.